Hoba Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$24.8M
Hoba Therapeutics is a biotech firm specializing in developing novel treatments for painful Chemotherapy-Induced Peripheral Neuropathy and sensorineural hearing loss, currently advancing their lead drug candidate, HB-086, towards Phase 1 clinical trials.
Focus Areas
Biotechnology
Drug Development
Clinical Trials
Peripheral Neuropathy Treatment
Hearing Loss Treatment
Pre-Clinical Research
Investors
